(Q35834193)

10 August 2017

1 reference

title

Angiotensin-converting enzyme inhibitors side effects--physiologic and non-physiologic considerations (English)

1 reference

10 August 2017

Domenic A Sica

1

1 reference

10 August 2017

publication date

1 July 2004

1 reference

Journal of Clinical Hypertension

10 August 2017

published in

1 reference

10 August 2017

volume

6

1 reference

10 August 2017

issue

7

1 reference

10 August 2017

page(s)

410-416

1 reference

Ramipril: a review of its use in the prevention of cardiovascular outcomes

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

The Heart Outcomes Prevention Evaluation study: angiotensin-converting enzyme inhibitors: are their benefits a class effect or do individual agents differ?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Dosage considerations with perindopril for systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Angiotensin-II-receptor inhibitors in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Treating hypertension in women of child-bearing age and during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Drug-drug interactions among elderly patients hospitalized for drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Treatment of ACE inhibitor-induced cough

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Angioedema due to ACE inhibitors: increased risk in patients of African origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Intermittent visceral edema induced by long-term enalapril administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Association between ACE inhibitors and acute pancreatitis in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

The pharmacokinetics and pharmacodynamics of angiotensin-receptor blockers in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Comparison of the effects of enalapril and losartan on posttransplantation erythrocytosis in renal transplant recipients: prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Angiotensin-converting enzyme inhibitors as inducers of adverse cutaneous reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Reduction in the therapeutic intensity of abortive migraine drug use during ACE inhibition therapy--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Association between ACE inhibitors use and headache caused by nitrates among hypertensive patients: results from the Italian group of pharmacoepidemiology in the elderly (GIFA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Do calcium channel blockers increase the risk of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Antihypertensive therapy and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Angiotensin-converting enzyme inhibitors and lithium toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Fever, myalgia, and arthralgia in a patient on captopril and allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

Angiotensin-Converting Enzyme Inhibitors, Calcium Channel Blockers, and Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02866.X

10.1111/J.1524-6175.2004.02866.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference